Hans Christian Hagedorn
Hans Christian Hagedorn (6 September 1888 – 6 October 1971) was a Danish physician and biochemist known for his significant contributions to the field of diabetes treatment. He is best known for co-discovering NPH insulin (Neutral Protamine Hagedorn insulin), which became a cornerstone in diabetes management.
Early Life and Education[edit | edit source]
Hans Christian Hagedorn was born in Copenhagen, Denmark. He pursued his medical studies at the University of Copenhagen, where he developed an interest in biochemistry and endocrinology.
Career and Research[edit | edit source]
Hagedorn's career was marked by his dedication to improving the lives of people with diabetes. In 1922, he co-founded the Nordisk Insulinlaboratorium (now part of Novo Nordisk) with August Krogh, a Nobel laureate. This institution was pivotal in the production and distribution of insulin in Europe.
Discovery of NPH Insulin[edit | edit source]
One of Hagedorn's most notable achievements was the development of NPH insulin in 1946. This form of insulin, which combines insulin with the protein protamine, allows for a slower absorption rate, providing more stable blood glucose levels for patients. NPH insulin remains widely used in diabetes treatment today.
Legacy[edit | edit source]
Hagedorn's work has had a lasting impact on the field of diabetes care. The Hagedorn Research Institute, named in his honor, continues to be a leading center for diabetes research. His contributions have improved the quality of life for millions of people with diabetes worldwide.
Personal Life[edit | edit source]
Hagedorn was married and had children. He remained active in his research and professional activities until his death in 1971.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD